Afanat 30 mg Tablet

Description

Afanat 30 mg Tablet contains Afatinib, a targeted cancer medicine used in the treatment of non-small cell lung cancer (NSCLC) that carries specific EGFR (epidermal growth factor receptor) mutations. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking the signals that promote cancer cell growth and spread. This medicine is prescribed as a first-line therapy for adults with metastatic NSCLC and may also be used in patients who have not responded to prior chemotherapy. Afanat helps slow the progression of cancer, improve symptoms, and extend survival in suitable patients. Key Benefits: Specifically targets EGFR-positive lung cancer cells Slows tumour growth and spread Taken orally once daily Trusted formulation by Natco Pharma Dosage & Administration:Take one tablet daily, or as prescribed by your oncologist. It should be taken on an emp